Healthcare provider profile · identity verified

Xiaoyu Hou

Internal Medicine · MINNEAPOLIS, MN · NPI 1053636886

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	541	166
Atorvastatin Calcium	Atorvastatin Calcium	519	144
Levothyroxine Sodium	Levothyroxine Sodium	261	74
Lisinopril	Lisinopril	226	71
Omeprazole	Omeprazole	221	63
Metoprolol Succinate	Metoprolol Succinate	171	56
Gabapentin	Gabapentin	163	43
Losartan Potassium	Losartan Potassium	148	52
Simvastatin	Simvastatin	133	38
Tamsulosin Hcl	Tamsulosin Hcl	132	42
Methylprednisolone	Methylprednisolone	117	71
Trazodone Hcl	Trazodone Hcl	116	41
Rosuvastatin Calcium	Rosuvastatin Calcium	111	40
Eliquis	Apixaban	110	33
Metformin Hcl Er	Metformin Hcl	109	35
Albuterol Sulfate Hfa	Albuterol Sulfate	103	30
Pantoprazole Sodium	Pantoprazole Sodium	100	27
Escitalopram Oxalate	Escitalopram Oxalate	88	25
Metformin Hcl	Metformin Hcl	83	25
Citalopram Hbr	Citalopram Hydrobromide	77	27
Prednisone	Prednisone	74	33
Lorazepam	Lorazepam	73	15
Allopurinol	Allopurinol	72	21
Hydrochlorothiazide	Hydrochlorothiazide	72	24
Metoprolol Tartrate	Metoprolol Tartrate	72	24
Furosemide	Furosemide	67	24
Sertraline Hcl	Sertraline Hcl	66	23
Atenolol	Atenolol	57	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	24
Triamcinolone Acetonide	Triamcinolone Acetonide	57	25
Azithromycin	Azithromycin	56	38
Carvedilol	Carvedilol	54	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	17
Xarelto	Rivaroxaban	48	15
Zolpidem Tartrate	Zolpidem Tartrate	47	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	14
Finasteride	Finasteride	45	15
Pravastatin Sodium	Pravastatin Sodium	45	13
Fluticasone Propionate	Fluticasone Propionate	44	17
Alprazolam	Alprazolam	40	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	40	12
Famotidine	Famotidine	39	14
Labetalol Hcl	Labetalol Hcl	39	14
Glimepiride	Glimepiride	37	13
Warfarin Sodium	Warfarin Sodium	36	suppressed
Ozempic	Semaglutide	35	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Pregabalin	Pregabalin	30	suppressed
Jardiance	Empagliflozin	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Glipizide Er	Glipizide	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	16
Nitroglycerin	Nitroglycerin	22	11
Ezetimibe	Ezetimibe	21	suppressed
Meloxicam	Meloxicam	21	suppressed
Latanoprost	Latanoprost	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Amoxicillin	Amoxicillin	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Estradiol	Estradiol	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Valsartan	Valsartan	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Lithium Carbonate	Lithium Carbonate	17	suppressed
Baclofen	Baclofen	16	suppressed
Glipizide	Glipizide	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Diazepam	Diazepam	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Temazepam	Temazepam	11	suppressed
Torsemide	Torsemide	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error